Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 Jan;85(1):87-91.
doi: 10.1136/heart.85.1.87.

Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients

Affiliations
Clinical Trial

Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients

K Kiuchi et al. Heart. 2001 Jan.

Abstract

Objective: To assess whether the concentrations of serum advanced glycation end products (AGE) in diabetic patients with obstructive coronary artery disease differ from those in type 2 diabetic patients without obstructive coronary artery disease.

Design: Serum AGE concentrations were measured in type 2 diabetic patients and in non-diabetic patients, both with and without obstructive coronary artery disease, and the relation between these values and coronary disease severity was evaluated.

Results: Mean (SD) serum AGE concentrations were higher (p < 0.0125) in type 2 diabetic patients with obstructive coronary artery disease (5.5 (2.5) mU/ml, n = 30) than in patients without obstructive coronary artery disease (2.8 (0. 5) mU/ml, n = 12), and higher than in non-diabetic patients with (3. 4 (1.0) mU/ml, n = 28) and without (3.2 (0.4) mU/ml, n = 13) obstructive coronary artery disease. Serum AGE was associated with the degree of coronary arteriosclerosis in type 2 diabetic patients with obstructive coronary artery disease (single vessel: n = 13, 3.4 (0.9) mU/m; two vessel: n = 6, 5.7 (1.6) mU/m; three vessel: n = 11, 7.2 (2.5) mU/ml). Serum AGE was positively correlated with serum mean four year HbA(1C) (r = 0.46, p < 0.01), but not with recent serum HbA(1C) (r = 0.24). The four groups did not differ in the other coronary risk factors.

Conclusions: Serum AGE concentrations may be associated with long term poor glycaemic control and reflect the severity of coronary arteriosclerosis in type 2 diabetic patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatterplot showing relation between AGE and recent HbA1C (left), and mean four year HbA1C (right). Recent HbA1C was not correlated with serum AGE, whereas there was a significant but weak correlation between mean four year HbA1C and serum AGE (r = 0.46, p < 0.01).
Figure 2
Figure 2
Serum AGE concentrations and the severity of coronary arteriosclerosis in the diabetic patients with obstructive coronary artery disease. Serum AGE increased with the severity of coronary arteriosclerosis in the diabetic patients with obstructive coronary artery disease.
Figure 3
Figure 3
Serum AGE concentrations and the severity of coronary arteriosclerosis in the non-diabetic patients with obstructive coronary artery disease. Serum AGE did not increase in these patients and did not correlate with the severity of the coronary arteriosclerosis.

Similar articles

Cited by

References

    1. Clin Chim Acta. 1968 Nov;22(3):393-7 - PubMed
    1. Diabetes Care. 1999 Sep;22(9):1543-8 - PubMed
    1. Clin Chem. 1973 Dec;19(12):1350-6 - PubMed
    1. J Lipid Res. 1982 Nov;23(8):1206-23 - PubMed
    1. N Engl J Med. 1988 May 19;318(20):1315-21 - PubMed

Publication types